322 related articles for article (PubMed ID: 32854430)
1. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection.
Aslam M; Ladilov Y
Cells; 2020 Aug; 9(9):. PubMed ID: 32854430
[TBL] [Abstract][Full Text] [Related]
2. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.
Yang N; Shen HM
Int J Biol Sci; 2020; 16(10):1724-1731. PubMed ID: 32226290
[TBL] [Abstract][Full Text] [Related]
4. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.
Abu-Farha M; Thanaraj TA; Qaddoumi MG; Hashem A; Abubaker J; Al-Mulla F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429572
[TBL] [Abstract][Full Text] [Related]
5. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
6. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Ballout RA; Sviridov D; Bukrinsky MI; Remaley AT
FASEB J; 2020 Jun; 34(6):7253-7264. PubMed ID: 32367579
[TBL] [Abstract][Full Text] [Related]
7. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
Sauvat A; Ciccosanti F; Colavita F; Di Rienzo M; Castilletti C; Capobianchi MR; Kepp O; Zitvogel L; Fimia GM; Piacentini M; Kroemer G
Cell Death Dis; 2020 Aug; 11(8):656. PubMed ID: 32814759
[TBL] [Abstract][Full Text] [Related]
8. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
9. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
[TBL] [Abstract][Full Text] [Related]
11. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
12. α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.
Williams SJ; Goddard-Borger ED
Biochem Soc Trans; 2020 Jun; 48(3):1287-1295. PubMed ID: 32510142
[TBL] [Abstract][Full Text] [Related]
13. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
[TBL] [Abstract][Full Text] [Related]
14. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
15. Cationic drugs and COVID-19.
Brenna OV; Torretta S; Pignataro L; Di Berardino F
Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
[TBL] [Abstract][Full Text] [Related]
16. Vimentin as a target for the treatment of COVID-19.
Li Z; Paulin D; Lacolley P; Coletti D; Agbulut O
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32913008
[TBL] [Abstract][Full Text] [Related]
17. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.
Asghari A; Naseri M; Safari H; Saboory E; Parsamanesh N
DNA Cell Biol; 2020 Oct; 39(10):1741-1753. PubMed ID: 32716648
[TBL] [Abstract][Full Text] [Related]
18. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
Cava C; Bertoli G; Castiglioni I
BMC Pharmacol Toxicol; 2020 Sep; 21(1):65. PubMed ID: 32883368
[TBL] [Abstract][Full Text] [Related]
19. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.
Soleimani M
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380787
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
Baig MS; Alagumuthu M; Rajpoot S; Saqib U
Drugs R D; 2020 Sep; 20(3):161-169. PubMed ID: 32592145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
